Get an alert when SARTORIUS ALBUMEDIX LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Cash

£250K

0% vs 2024

Net assets

£48M

+5.7% highest in 3 filed years

Employees

125

+0.8% highest in 3 filed years

Profit before tax

£14M

-6% vs 2024

Accounts

3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31

Metric Trend 2023-12-312024-12-312025-12-31 Δ vs prior
Turnover £34,492,000£35,562,000£30,919,000 -13.1%
Operating profit £12,855,000£15,522,000£13,719,000 -11.6%
Profit before tax £12,252,000£15,206,000£14,289,000 -6%
Net profit £11,981,000£12,030,000£11,575,000 -3.8%
Cash £251,000£250,000£250,000 0%
Total assets less current liabilities £37,288,000£51,289,000£54,558,000 +6.4%
Net assets £33,299,000£45,329,000£47,904,000 +5.7%
Equity £33,299,000£45,329,000£47,904,000 +5.7%
Average employees 122124125 +0.8%
Wages £7,531,000£6,943,000£7,445,000 +7.2%
Directors' remuneration £455,000£357,000£365,000 +2.2%

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show . About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-312025-12-31
Operating margin 37.3%43.6%44.4%
Net margin 34.7%33.8%37.4%
Return on capital employed 34.5%30.3%25.1%
Current ratio 1.52x5.83x7.80x
Interest cover 21.32x48.36x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Name history

Renamed 6 times since incorporation

  1. SARTORIUS ALBUMEDIX LIMITED 2024-05-28 → present
  2. ALBUMEDIX LTD 2016-01-18 → 2024-05-28
  3. NOVOZYMES BIOPHARMA UK LIMITED 2007-09-17 → 2016-01-18
  4. NOVOZYMES DELTA LIMITED 2006-07-14 → 2007-09-17
  5. DELTA BIOTECHNOLOGY LIMITED 1984-09-21 → 2006-07-14
  6. CORAL TOURIST SERVICES LIMITED 1977-12-31 → 1984-09-21
  7. TWINHEATH LIMITED 1973-10-29 → 1977-12-31

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
Rödl & Partner Limited
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The Company meets its day-to-day working capital requirements from cash flows generated from operations and cash pooling arrangements with Sartorius. In evaluating the going concern assumption, the directors noted the Company's strong positive cash flow position and have prepared cash flow forecasts together with sensitivity ana”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

3 active · 45 resigned

Name Role Appointed Born Nationality
FABER, Rene, Dr. Director 2022-09-30 Jul 1975 Slovak
KALINOWSKI, Mark Director 2023-12-18 Nov 1965 British
WOODWARD, Stuart Director 2023-12-18 Jan 1967 British
Show 45 resigned officers
Name Role Appointed Resigned
DAVIES, William Robert Secretary 1996-05-17 1996-10-25
DIAMOND, Charlotte Ann Secretary 2019-05-20 2026-07-01
REED, Bryan James Secretary 1991-11-22 1996-05-17
THORPE, Andrew Julian Secretary 1996-10-25 2019-05-20
BOURGART, Joseph Francis Director 1996-05-13 1996-05-17
CAPETOLA, Robert J Director 1994-03-31 1996-05-17
CLUBB, Ian Mcmaster Director 1991-11-22 1994-09-30
CONNELL, William Edward Director 1996-05-17
DE WIT, Hugo Laurens Director 2022-09-30 2024-04-01
DEBETHIZY, Joseph Donald Director 2017-12-28 2022-09-30
DEGN, Pia Botting Director 2015-01-30 2015-12-31
EPSTEIN, Gil Director 1996-05-17 1996-10-22
FUHGE, Peter Director 1996-05-17 2000-10-13
GARLAND, Stephen George Director 1998-03-02 2006-07-06
GRAM, Anders Peter Director 2006-07-06 2007-06-04
ISAAC, Anthony Eric Director 1994-10-17 1996-05-17
JENSEN, Camilla Kinch Director 2015-12-31 2017-12-28
JENSEN, Randi Camilla Kinch Director 2006-07-06 2008-02-08
KIRK, Christopher William Director 1991-11-22 1993-01-11
KORGAARD-MOLLERUP, Soren Director 2011-06-06 2015-01-30
MCGLYNN, Martin M Director 1991-11-22 1994-02-09
MCGLYNN, Martin M Director 1994-02-09
MERKLE, Werner Director 1998-03-02 2006-07-06
MERSER, Kristian Director 2006-07-06 2009-09-01
MOLLER, Jonas Skjodt Director 2018-08-23 2023-12-18
MOORE, Margaret Wallis Director 1996-05-14 1996-05-17
MURA, Henri Director 1996-05-17 1997-01-31
MURPHY, John Marcus Director 1991-11-22 1992-07-31
NIELSEN, Jacob Director 2009-09-01 2011-06-06
PRECHT, Tobias Director 2022-09-30 2023-12-18
ROSHOLM, Peter Director 2017-12-28 2022-09-30
ROSHOLM, Peter Director 2007-06-04 2015-12-31
SAITH, Vijay Kumar Director 1996-05-17
SCHMIDT, Arne Wintherhalter Director 2006-07-06 2007-09-30
SCHULZE, Gail Director 1998-03-02 2003-11-28
SEDOR, John A Director 1996-05-17 1998-01-30
SLEEP, Darrell, Dr Director 2016-01-01 2017-12-21
STEFFENSEN, Uno Bonde Director 2008-02-08 2009-09-01
STOLL, Roger Gerhard, Dr Director 1994-02-09 1996-05-17
STUART, Gloria Jean Director 1994-06-01 1996-05-17
TARALLO, Angelo Nicholas Director 1994-06-01
THOMAS, Paul Director 1994-02-09 1996-05-17
THORPE, Andrew Julian Director 2017-12-28 2022-09-30
THORPE, Andrew Julian Director 1998-03-02 2006-07-06
VILTOFT, Mikkel Director 2009-09-01 2017-12-28

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Sartorius Stedim Biotech S.A. Corporate entity Shares 75–100%, Voting 75–100% 2022-09-30 Active
Mr Peter Rosholm Individual Shares 75–100%, Voting 75–100%, Appoints directors 2017-12-28 Ceased 2022-09-30
Albumedix A/S Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2016-04-06 Ceased 2017-12-28

Filing timeline

Last 20 of 254 total filings

Material constitutional events — rename, articles re-file, resolution

  • 2024-05-28 CERTNM Certificate change of name company PDF
Date Type Category Description
2026-07-02 TM02 officers Termination secretary company with name termination date PDF
2026-06-24 AA accounts Accounts with accounts type full
2026-01-30 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-09-17 AA accounts Accounts with accounts type full
2025-01-28 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-07-12 AA accounts Accounts with accounts type full
2024-05-28 CERTNM change-of-name Certificate change of name company PDF
2024-05-13 MR04 mortgage Mortgage satisfy charge full PDF
2024-04-11 TM01 officers Termination director company with name termination date PDF
2024-01-26 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-12-19 AP01 officers Appoint person director company with name date PDF
2023-12-19 AP01 officers Appoint person director company with name date PDF
2023-12-19 TM01 officers Termination director company with name termination date PDF
2023-12-19 TM01 officers Termination director company with name termination date PDF
2023-10-11 AA accounts Accounts with accounts type full
2023-01-26 CS01 confirmation-statement Confirmation statement with updates PDF
2023-01-04 PSC05 persons-with-significant-control Change to a person with significant control PDF
2022-11-03 CH01 officers Change person director company with change date PDF
2022-11-03 TM01 officers Termination director company with name termination date PDF
2022-10-19 PSC07 persons-with-significant-control Cessation of a person with significant control PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
4

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page